Siemens Healthineers AG (SMMNY)
R&D to Revenue
8.33%
Fiscal year · Period ending:

SMMNY R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
SMMNY r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 8.3326% | −0.04 pts | |
| 8.3765% | −0.20 pts | |
| 8.5767% | −0.03 pts | |
| 8.607% | +0.39 pts | |
| 8.2205% | −0.37 pts | |
| 8.5903% | −0.69 pts | |
| 9.2808% | +0.13 pts | |
| 9.1473% | −0.39 pts | |
| 9.5391% | +0.38 pts | |
| 9.1614% | +0.71 pts | |
| 8.4521% | +0.30 pts | |
| 8.1555% | — |
Frequently asked questions: SMMNY r&d to revenue
What is Siemens Healthineers AG (SMMNY)'s current r&d to revenue?
Siemens Healthineers AG (SMMNY)'s latest reported r&d to revenue (Fiscal year) is 8.33% as of Sep 30, 2026. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for SMMNY?
Stock Alarm Pro provides 12 dated annual fiscal periods observations for Siemens Healthineers AG (SMMNY)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare SMMNY's r&d to revenue to peers or set an alert?
You can open SMMNY's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SMMNY delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance